Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lois M Mulligan

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|May 28, 2010
The highs and lows of PITX2: comment on: Huang, et al. Cell Cycle 2010; 9:1333-41Lois M Mulligan
Frontiers in Physiology|January 23, 2019
GDNF and the RET Receptor in Cancer: New Insights and Therapeutic PotentialLois M Mulligan
Expert Review of Proteomics|June 24, 2016
Progress and potential impact of RET kinase targeting in cancerLois M Mulligan
Nature Reviews. Cancer|February 25, 2014
RET revisited: expanding the oncogenic portfolioLois M Mulligan
Endocrine-Related Cancer|May 11, 2018
65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicineLois M Mulligan
Cancer Treatment and Research|October 8, 2005
From genes to decisions: evolving views of genotype-based management in MEN 2Lois M Mulligan
Endocrine-Related Cancer|September 14, 2017
Happy 20th anniversary <i>MEN1</i>: from positional cloning to gene function restorationFrank Weber, Lois M Mulligan
Cancer Research|July 3, 2004
The RET receptor is linked to stress response pathwaysShirley M Myers, Lois M Mulligan
Annals of the New York Academy of Sciences|November 15, 2006
Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2Taranjit S Gujral, Lois M Mulligan
Endocrine-Related Cancer|October 23, 2024
Cellular mechanisms of RET receptor dysfunction in multiple endocrine neoplasia 2Timothy J Walker, Lois M Mulligan
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|May 28, 2010
The highs and lows of PITX2: comment on: Huang, et al. Cell Cycle 2010; 9:1333-41Lois M Mulligan
Frontiers in Physiology|January 23, 2019
GDNF and the RET Receptor in Cancer: New Insights and Therapeutic PotentialLois M Mulligan
Expert Review of Proteomics|June 24, 2016
Progress and potential impact of RET kinase targeting in cancerLois M Mulligan
Nature Reviews. Cancer|February 25, 2014
RET revisited: expanding the oncogenic portfolioLois M Mulligan
Endocrine-Related Cancer|May 11, 2018
65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicineLois M Mulligan
Cancer Treatment and Research|October 8, 2005
From genes to decisions: evolving views of genotype-based management in MEN 2Lois M Mulligan
Endocrine-Related Cancer|September 14, 2017
Happy 20th anniversary <i>MEN1</i>: from positional cloning to gene function restorationFrank Weber, Lois M Mulligan
Cancer Research|July 3, 2004
The RET receptor is linked to stress response pathwaysShirley M Myers, Lois M Mulligan
Annals of the New York Academy of Sciences|November 15, 2006
Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2Taranjit S Gujral, Lois M Mulligan
Endocrine-Related Cancer|October 23, 2024
Cellular mechanisms of RET receptor dysfunction in multiple endocrine neoplasia 2Timothy J Walker, Lois M Mulligan
Pageof 5